Biomarkers of Renal Cancer
- Status
- RECRUITING
- Phase
- N/A
Clinical Trials Related to Renal Cell Carcinoma
Related studies linked through entity extraction aliases.
Study of JANX008 in Subjects With Advanced or Metastatic Solid Tumor Malignancies
- Status
- RECRUITING
- Phase
- PHASE1
DETERMINE Trial Treatment Arm 01: Alectinib in Adult, Paediatric and Teenage/Young Adult Patients With ALK Positive Cancers
- Status
- RECRUITING
- Phase
- PHASE2/PHASE3
Study of RO7515629 in Participants With HLA-G Positive Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1
CD8 Minibody Repeatability Study
- Status
- TERMINATED
- Phase
- PHASE2
The Efficacy and Safety of Chinese Domestic Surgical Robot System in Urological Telesurgery
- Status
- UNKNOWN
- Phase
- NA
Neoadjuvant of Axitinib Plus PD-1 to Improve Disease Free Survival of Patients With Renal Cell Carcinoma
- Status
- RECRUITING
- Phase
- PHASE3
Neoadjuvant Pembrolizumab and Lenvatinib for Renal Cell Carcinoma
- Status
- RECRUITING
- Phase
- EARLY_PHASE1
Transplantation of Reconstructed Renal Allografts Following Ex-Vivo Partial Nephrectomy
- Status
- RECRUITING
- Phase
- NA
Trial of PRO1160 (GEN1160) in Relapsed or Refractory Non-Hodgkin Lymphoma (NHL) (PRO1160-001)
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
NUC-3373 in Combination With Other Agents in Patients With Advanced Solid Tumours
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
A Companion Diagnostic Study to Develop Circulating Exosomes as Predictive Biomarkers for the Response to Immunotherapy in Renal Cell Carcinoma
- Status
- RECRUITING
- Phase
- N/A
Comparing Single vs Multiple Dose Radiation for Cancer Patients With Brain Metastasis and Receiving Immunotherapy
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- NA
Drug Screening Using Novel IMD in Renal Cell Carcinoma
- Status
- RECRUITING
- Phase
- PHASE1
A Study to Investigate the Antitumor Activity, Safety, Tolerability, and Pharmacokinetics of BGB-A445 in Combination With Tislelizumab in Participants With Select Advanced Solid Tumors.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
A Study Evaluating AB248 Alone or in Combination With Pembrolizumab in Adult Patients With Solid Tumors
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Treatment Outcomes in Japanese RCC Patients Treated With Avelumab Plus Axitinib as First-line Therapy: Retrospective Study (J-DART2)
- Status
- COMPLETED
- Phase
- N/A
Contrast-Enhanced Ultrasound Imaging for Diagnosing Recurrent Renal Cell Carcinoma (RCC) Post Ablation
- Status
- RECRUITING
- Phase
- PHASE2
68Ga-labeled NY104 PET Imaging in Patients
- Status
- UNKNOWN
- Phase
- EARLY_PHASE1
Quantifying Systemic Immunosuppression to Personalize Cancer Therapy
- Status
- RECRUITING
- Phase
- N/A